Madeleine G. Barber
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CBRE Faces Broker Departures as Q3 Outlook Looms. Recent reports show several senior brokers have left CBRE for rivals such as Cushman & Wakefield and JLL, including a recent wave of Chicago executives. The departures come as analysts and investors look ahead to CBRE’s third‑quarter results, which have been described as a “winning streak.” At the same time, office vacancy rates in markets like Dallas‑Fort Worth have fallen, suggesting continued demand for commercial space. These developments could influence the company’s brokerage revenue and overall performance.
Transaction History
| DD | ▼ Sell | Tax Withholding | 101 | $15K | 8/6/2026 | View on chart |
| DD | ▲ Buy | Grant | 2,778 | $0 | 2/20/2026 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 1,265 | $121K | 3/3/2022 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 1,293 | $125K | 2/28/2022 | View on chart |
| CBRE | ▲ Buy | Grant | 4,055 | $0 | 2/25/2022 | View on chart |
| CBRE | ▲ Buy | Grant | 5,312 | $0 | 2/18/2022 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 639 | $65K | 2/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
DuPont receives analyst upgrades and announces quarterly dividend
DuPont de Nemours was highlighted in several recent analyst reports. RBC Capital kept an Outperform rating while lowering its price target to $160, and Barclays began coverage with an Overweight rating and a $156 target. The company also announced its regular quarterly dividend for common stock. These developments show ongoing analyst attention and a focus on returning cash to shareholders.
DuPont receives analyst upgrades and announces quarterly dividend. DuPont de Nemours was highlighted in several recent analyst reports. RBC Capital kept an Outperform rating while lowering its price target to $160, and Barclays began coverage with an Overweight rating and a $156 target. The company also announced its regular quarterly dividend for common stock. These developments show ongoing analyst attention and a focus on returning cash to shareholders.